Prot# Perifosine 212: An Open-Label Phase II Study of the Safety and Efficacy of Perifosine Alone and in Combination with Dexamethasone for Patients with Relapsed or Relapsed/Refractory Multiple Myeloma

Project: Research project

Project Details

StatusFinished
Effective start/end date5/3/065/3/11

Funding

  • AOI Pharmaceuticals, Inc. (Perifosine 212)